Nicox Analyst Coverage Initiated by Edison Investment Research Jan 22, 2021 01:30AM
Nicox Analyst Coverage Initiated by Kepler Cheuvreux Nov 25, 2020 02:00AM
Nicox announces licensing agreement with Eyevance for commercialization of ZERVIATETM in the United States Sep 21, 2017 01:31AM
Nicox to present at the Cantor Fitzgerald 2017 Global Healthcare Conference Sep 19, 2017 11:46AM
Nicox first half 2017 business and financial update Sep 8, 2017 01:32AM


Jun 15, 2017 11:46AM Nicox to present at the 2017 BIO International Convention
Jun 8, 2017 02:01PM Nicox: Issuing and admission to trading on the Euronext regulated market in Paris of 597,897 new shares awarded to existing Aciex shareholders following the US FDA's approval of ZERVIATE
May 31, 2017 09:01AM Nicox receives FDA approval of ZERVIATE1 (cetirizine ophthalmic solution) 0.24%
May 17, 2017 01:31AM Ms. Lauren P. Silvernail appointed to Nicox Board of Directors
May 9, 2017 01:32AM Nicox announces the presentation of scientific data on NCX 667 at ARVO 2017
Apr 27, 2017 01:31AM Nicox first quarter 2017 business update and cash position
Jul 8, 2016 04:04AM Nicox to present at Cantor Fitzgerald's 2nd Annual Healthcare Conference
Jul 5, 2016 01:33AM Nicox to transfer Commercial Operations to new pan-European Ophthalmic Specialty Pharmaceutical Company led by GHO Capital
Jun 27, 2016 01:33AM Nicox added to Russell Global Index
Jun 21, 2016 02:29AM U.S. FDA grants Priority Review for Nicox's AC-170 New Drug Application
May 10, 2016 01:36AM Nicox first quarter 2016 financial and business update
May 9, 2016 01:33AM Nicox announces the presentation of scientific data at ARVO 2016
Apr 19, 2016 02:52AM Nicox submits New Drug Application for AC-170 to U.S. FDA